Octave Bioscience Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $14M
Latest Deal Amount
  • Investors
  • 5

Octave Bioscience General Information

Description

Developer of an integrated care management system designed to deliver insights of patients with neurodegenerative diseases. The company's system offers an end-to-end care management platform that combines quantitative measurements with analytics tools to evaluate neurodegenerative disease pathways, enabling neurologists to get robust, objective metrics to facilitate informed care and shared decision making for better patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 1440 Obrien Drive
  • Suite B
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Octave Bioscience Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Octave Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 12-Jul-2018 $14M 000.00 0000 Completed Generating Revenue
1. Seed Round 13-Sep-2017 00.00 00.00 00.000 Completed Generating Revenue
To view Octave Bioscience’s complete valuation and funding history, request access »

Octave Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00 00 00 00 00 00.00
To view Octave Bioscience’s complete cap table history, request access »

Octave Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an integrated care management system designed to deliver insights of patients with neurodegenerative diseas
Decision/Risk Analysis
Menlo Park, CA
000.00
000 0000-00-00
00000000000 000.00

00000000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
00000 0000000000 0000000000 0000000
Atlanta, GA
000 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

00000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non
0000000000000 00000000
Philadelphia, PA
00 As of 0000
00.00
0000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Octave Bioscience Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oncology Analytics Venture Capital-Backed Atlanta, GA 000 000.00 00000000000 000.00
00000 Angel-Backed Philadelphia, PA 00 00.00 0000000000 00.00
00000 000000 Corporate Backed or Acquired Washington, DC 0000 000000000000
000000000 Private Equity-Backed North Port, FL 0000 00000 000000000 - 00000
000000000 000000 Private Equity-Backed Reston, VA 000 000.00 000000000 00 000.00
You’re viewing 5 of 18 competitors. Get the full list »

Octave Bioscience Executive Team (4)

Name Title Board Seat Contact Info
William Hagstrom Co-Founder, Chief Executive Officer & Board Member
Melinda Thomas Co-Founder & Chief Operating Officer
Erwan Rivet Chief Technology Officer
Michael Becich Platform Insights Lead
To view Octave Bioscience’s complete executive team members history, request access »

Octave Bioscience Board Members (6)

Name Representing Role Since
A. Grant Heidrich III Self Board Member 000 0000
Brook Byers Ph.D Kleiner Perkins Board Member 000 0000
George Scangos Ph.D Self Board Member 000 0000
Michael Pellini MD Section 32 Board Member 000 0000
Thomas Hawes MD Sandbox Industries Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Octave Bioscience Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Echo Health Ventures Venture Capital Minority 000 0000 000000 0
Sandbox Industries Venture Capital Minority 000 0000 000000 0
Section 32 Venture Capital Minority 000 0000 000000 0
Blue Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Kleiner Perkins Venture Capital Minority 000 0000 000000 0
To view Octave Bioscience’s complete investors history, request access »